Op-Eds
Are We in a Brave New World of “Personalized” Medicine?
BiDil, a new drug labeled for treatment of blacks with severe heart failure, has begun to arrive in pharmacies. Approved by FDA in…
Op-Eds
Competition and the Telecom Marketplace
Holman Jenkins addresses one of the many sticking points for broadband deployment — cities and localities. Indeed, in today's communications landscape dominated by…
Op-Eds
More Crop for the Drop
The worst East Central U.S. drought in almost 20 years is decimating harvests of corn and soybeans, threatening farmers’ economic survival and disrupting commercial shipping…
Op-Eds
Goldman at Ground Zero
Op-Eds
Nationalizing Science
It seems as if you can’t turn anywhere without hearing that industry is destroying science these days. Former editors of the New England Journal of…
Op-Eds
To the Ashtray of History
Was this what was promised? Billions of dollars later and more than six years after the tobacco settlement was signed, American taxpayers and consumers deserve…